Literature DB >> 7563222

Experimental strategies to promote central nervous system remyelination in multiple sclerosis: insights gained from the Theiler's virus model system.

D J Miller1, K Asakura, M Rodriguez.   

Abstract

The destruction of central nervous system (CNS) myelin, the lipid-rich insulator surrounding axons in the mammalian brain and spinal cord, is the primary pathological finding in multiple sclerosis. Myelin loss can result in a significant clinical deficit, and was originally thought to be permanent, similar to axonal destruction. However, myelin regeneration is now an established phenomenon in both human disease and animal models of CNS demyelination. In this review, the concept of remyelination in demyelinating diseases such as multiple sclerosis is discussed and the usefulness of animal models of CNS demyelination in developing experimental strategies to promote remyelination is examined. Special emphasis is given to the Theiler's murine encephalomyelitis model, which has been the primary animal model used to investigate therapies designed specifically to stimulate myelin repair.

Entities:  

Mesh:

Year:  1995        PMID: 7563222     DOI: 10.1002/jnr.490410302

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  3 in total

1.  A transgenic mouse model for inducible and reversible dysmyelination.

Authors:  C Mathis; C Hindelang; M LeMeur; E Borrelli
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

2.  Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis.

Authors:  A E Warrington; K Asakura; A J Bieber; B Ciric; V Van Keulen; S V Kaveri; R A Kyle; L R Pease; M Rodriguez
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

Review 3.  Animal models of demyelination.

Authors:  M Bradl; C Linington
Journal:  Brain Pathol       Date:  1996-07       Impact factor: 6.508

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.